Shareprice
03 Jun 2026

Press & news

FluoGuide develops surgical solutions that is expected to reduce suffering for the patient and increases the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

Invitation to FluoGuide A/S live webcast on 27 May 2026

News


May 13, 2026

FluoGuide A/S will publish its interim report for Q1 2026 on Wednesday, 27 May 2026.

Later that day, CEO Morten Albrechtsen and CFO Ole Larsen will present the company’s operational and financial results for Q1 2026 in a live webcast. The webcast is hosted and moderated by Cecilia Hallström, BioStock.

The presentation will be followed by a live Q&A session, where questions can be asked during the event or submitted in advance by e-mail to redaktion@biostock.se.

Date: Wednesday 27 May 2026
Time: 14.00 CEST

Please login to the webcast via the following link: https://biostock.se/en/2026/05/live-q1-rapportkommentar-med-fluoguide-27-5/

Questions can be sent in advance by email to redaktion@biostock.se or can be raised at the question session during the webcast.

A recorded version of the presentation will be available on FluoGuide’s website after the webcast.